Fortune Smiles 88
赞并评论了
$Esperion Therapeutics (ESPR.US)$Esperion initiated with an Overweight at Cantor Fitzgerald - TipRanks.com BELOW is a Detailed research report that should convince readers to have a portion of their investment portfolio in Esperion. This is not a pump article, please take the time to read and fact check. This $2 stock will be $20+ by 2027. Esperion anticipates billions in Revenues.
Es...
Es...
已翻译
15
1
Fortune Smiles 88 : 我同意。低风险高回报的机会。一个月内克糖酮/克力泽的零售价格为每位患者400美元。假设仅在美国就有100万患者,Esperian每月的总销售额将达到40000万美元,年销售额接近50亿美元。将其推广到全球人口。潜力巨大。